Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17973 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Harutaka Seshimo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Alopecia, Antineoplastic Agents, Hematologic Diseases, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 14 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
It is known that hair loss occurs after chemotherapy, hematopoietic stem cell transplantation, and radiation, but the underlying mechanism, clinical and histopathological characteristics, and standard treatment among them remain unclear.
Method
We retrospectively investigated 17 Japanese patients with hematologic disorders who had hair loss after hematopoietic stem cell transplantation and chemotherapy with or without radiation therapy. Details of the treatment, trichoscopic, and histopathological findings were evaluated, and the therapeutic effects were assessed quantitatively.
Result
Diffuse hair loss was observed in all patients, with an average duration of 4.9 years. Cyclophosphamide was the most frequently used chemotherapeutic agent, while peripheral blood stem cell transplantation was the most common transplantation method. Trichoscopy showed short vellus hairs and hair diameter diversity. Histopathologically, the proportion of vellus hair and that of catagen/telogen hair increased. Treatment primarily targeting hair follicle miniaturization improved hair volume in 52.9% of cases.
Conclusion
Main pathology is considered the hair miniaturization rather than inflammation‐mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
- Department of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
ORCID-Profile: Harutaka Seshimo, Masaki Uchiyama, Takafumi Numata, Hiroaki Shimizu, Kazutoshi Harada
Zitieren
APA
Seshimo, H., Uchiyama, M., Suzuki, R., Numata, T., Irisawa, R., Shimizu, H., & Harada, K. (2025). Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17973
Vancouver
Seshimo H, Uchiyama M, Suzuki R, Numata T, Irisawa R, Shimizu H, et al. Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17973
BibTeX
@article{Seshimo2025,
author = {Seshimo, Harutaka and Uchiyama, Masaki and Suzuki, Risa and Numata, Takafumi and Irisawa, Ryokichi and Shimizu, Hiroaki and Harada, Kazutoshi},
title = {Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17973}
}
EUVIMED